Abstract
Novel bone-targeting prodrugs containing dendritic naproxen and poly(aspartic acid) oligopeptide were synthesized in a convergent approach and were characterized by NMR, mass spectral, and elemental analysis techniques. The modified naproxen prodrugs showed a high affinity to hydroxyapatite in vitro and provided an effective entry for the synthesis of a dendritic naproxen–poly(aspartic acid) oligopeptide conjugates used for bone targeting.
GRAPHICAL ABSTRACT
![](/cms/asset/9dd8da60-b8f6-40db-819d-ec114966f2d0/lsyc_a_584259_o_uf0001.gif)